Infrastructure Grant Scheme 2018 Letter of Intent Form ______________________________________________________________________________________________ APPLICATION TITLE INVESTIGATOR(S) Maximum of 10 investigators (including chief investigators and associate investigators) Chief Investigator(s) Name Current Appointment Institution Academic Qualification & year Associate Investigator(s) Title Name Current Appointment Institution CHIEF INVESTIGATOR A – CONTACT DETAILS Chief Investigator A will be considered the contact point for the application, acting on behalf of all Investigators Name (full name and title) Department: Institution: Address: City/Suburb: State Postcode Email 4. SYNOPSIS (300 word limit) Provide a brief summary of the research proposal including the significance of the problem, the requested infrastructure and the expected impact of the infrastructure on cancer control. AREA Select the area which best describe the research (select only one): KEYWORDS
Common Scientific Outline Select a maximum of 3 codes which best describe the research, using the highlight function in Word. Place an asterisk (*) next to the ONE broad CSO category which best describes the research (For example. 1. Biology) Full details of the Common Scientific Outline can be found at the International Cancer Research Portfolio website (). 1. Biology 1.1 Normal functioning 1.2 Cancer initiation: alterations in chromosomes 1.3 Cancer initiation: oncogenes and tumour suppressor genes 1.4 Cancer progression and metastasis 1.5 Resources and infrastructure 2. Aetiology 2.1 Exogenous factors in the origin and cause of cancer 2.2 Endogenous factors in the origin and cause of cancer 2.3 Interactions of genes/genetic polymorphisms with exogenous/endogenous factors 2.4 Resources and infrastructure related to aetiology 3. Prevention 3.1 Interventions to prevent cancer: personal behaviours that affect cancer risk 3.2 Nutritional science in cancer prevention 3.3 Chemoprevention 3.4 Vaccines 3.5 Complementary and alternative prevention approaches 3.6 Resources and infrastructure related to prevention 4. Early Detection, Diagnosis and Prognosis 4.1 Technology development and/or marker discovery 4.2 Technology and/or marker evaluation with respect to fundamental parameters of method 4.3 Technology and/or marker testing in a clinical setting 4.4 Resources and infrastructure related to detection, diagnosis and prognosis 5. Treatment 5.1 Localised therapies – discovery and development 5.2 Localised therapies – clinical applications 5.3 Systemic therapies – discovery and development 5.4 Systemic therapies – clinical applications 5.5 Combinations of localised and systemic therapies 5.6 Complementary and alternative treatment approaches 5.7 Resources and infrastructure related to treatment 6. Cancer Control, Survivorship and Outcomes Research 6.1 Patient care and survivorship issues 6.2 Surveillance 6.3 Behaviour 6.4 Cost analyses and healthcare delivery 6.5 Education and communication 6.6 End-of-Life care 6.7 Ethics and confidentiality in cancer research 6.8 Complementary and alternative approaches for supportive care of patients and survivors 6.9 Resources and infrastructure related to cancer control, survivorship and outcomes research